AMRZ Stock Analysis: Amerize | SW
Building Materials | SW, Switzerland | Market Cap: 22.125m CHF | 12M Return: -5.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 49.9M
Qual. Beats: 0
Rev. Trend: 94.4%
Warnings
Tailwinds
No distinct edge detected
Seasonality 1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Amrize AG is a Swiss-based building solutions provider serving infrastructure, commercial, and residential construction markets across North America. The company operates through two reporting segments: Building Materials, which supplies cement, aggregates, ready-mix concrete, and asphalt, and Building Envelope, which offers roofing and wall systems such as single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
The company is headquartered in Zug, Switzerland, and was incorporated in 2023. It was previously known as Holcim North America Finance Ltd, reflecting its origins as the North American arm of the global Holcim group before rebranding in December 2013.
Amrize operates within the capital-intensive building materials sector, where revenue is closely tied to North American construction cycles, including infrastructure spending and housing activity. The dual-segment structure combines upstream materials (cement and aggregates) with downstream building envelope products, giving the company exposure across the construction value chain from foundational inputs to finished exterior systems.
- US infrastructure bill funding lifts cement and aggregates demand
- Housing market weakness pressures roofing and ready-mix concrete volumes
- Carbon regulations and energy costs squeeze cement segment margins
| Net Income: 1.16b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.64 > 1.0 |
| NWC/Revenue: 10.33% < 20% (prev 17.58%; Δ -7.26% < -1%) |
| CFO/TA 0.04 > 3% & CFO 862.0m > Net Income 1.16b |
| Net Debt (-47.0m) to EBITDA (2.76b): -0.02 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (553.5m) vs 12m ago 0.14% < -2% |
| Gross Margin: 25.38% > 18% (prev 26.23%; Δ -0.85% > 0.5%) |
| Asset Turnover: 50.19% > 50% (prev 50.46%; Δ -0.27% > 0%) |
| Interest Coverage Ratio: 5.06 > 6 (EBIT TTM 1.85b / Interest Expense TTM 365.0m) |
| A: 0.05 (Total Current Assets 4.28b - Total Current Liabilities 3.05b) / Total Assets 24.3b |
| B: 0.03 (Retained Earnings 785.0m / Total Assets 24.3b) |
| C: 0.08 (EBIT TTM 1.85b / Avg Total Assets 23.7b) |
| D: 1.17 (Book Value of Equity 13.1b / Total Liabilities 11.2b) |
| Altman-Z'' = 2.19 = BBB |
| DSRI: 0.76 (Receivables 1.32b/1.71b, Revenue 11.9b/11.7b) |
| GMI: 1.03 (GM 26.23% / 25.38%) |
| AQI: 0.96 (AQ_t 0.45 / AQ_t-1 0.47) |
| SGI: 1.02 (Revenue 11.9b / 11.7b) |
| TATA: 0.01 (NI 1.16b - CFO 862.0m) / TA 24.3b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at CHF 40.05 with a total of 906,311 shares traded. Over the past week, the price has changed by -6.25%, over one month by -2.08%, over three months by -9.63% and over the past year by -5.49%.
Current recommended Stop Loss: 36.60 (which is 8.6% or 2.4 ATR below the current price).
Amerize has no consensus analysts rating.
Market Cap USD = 27.4b (22.1b CHF * 1.2392 CHF.USD)
P/E Trailing = 23.6509
P/E Forward = 18.6567
P/S = 1.8574
P/B = 2.2551
P/EG = 1.4381
Revenue TTM = 11.9b USD
EBIT TTM = 1.85b USD
EBITDA TTM = 2.76b USD
Long Term Debt = 4.94b USD (from longTermDebt, last quarter)
Short Term Debt = 1.11b USD (from shortLongTermDebt, last quarter)
Debt = 1.05b USD (Leases only: 1.05b)
Net Debt = -47.0m USD (calculated: Debt 1.05b - CCE 1.10b)
Enterprise Value = 27.4b USD (27.4b + Debt 1.05b - CCE 1.10b)
Interest Coverage Ratio = 5.06 (Ebit TTM 1.85b / Interest Expense TTM 365.0m)
EV/FCF = 20.75x (Enterprise Value 27.4b / FCF TTM 1.32b)
FCF Yield = 4.82% (FCF TTM 1.32b / Enterprise Value 27.4b)
FCF Margin = 11.07% (FCF TTM 1.32b / Revenue TTM 11.9b)
Net Margin = 9.70% (Net Income TTM 1.16b / Revenue TTM 11.9b)
Gross Margin = 25.38% ((Revenue TTM 11.9b - Cost of Revenue TTM 8.89b) / Revenue TTM)
Gross Margin QoQ = 9.69% (prev 26.77%)
Tobins Q-Ratio = 1.13 (Enterprise Value 27.4b / Total Assets 24.3b)
Interest Expense / Debt = 34.70% (Interest Expense 365.0m / Debt 1.05b)
Taxrate = 23.23% (345.0m / 1.49b)
NOPAT = 1.42b (EBIT 1.85b * (1 - 23.23%))
Current Ratio = 1.40 (Total Current Assets 4.28b / Total Current Liabilities 3.05b)
Debt / Equity = 0.08 (Debt 1.05b / totalStockholderEquity, last quarter 13.1b)
Debt / EBITDA = -0.02 (Net Debt -47.0m / EBITDA 2.76b)
Debt / FCF = -0.04 (Net Debt -47.0m / FCF TTM 1.32b)
Total Stockholder Equity = 12.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 1.16b / Total Assets 24.3b)
RoE = 8.95% (Net Income TTM 1.16b / Total Stockholder Equity 12.9b)
RoCE = 10.35% (EBIT 1.85b / Capital Employed (Equity 12.9b + L.T.Debt 4.94b))
RoIC = 6.88% (NOPAT 1.42b / Invested Capital 20.6b)
WACC = 9.51% (E(27.4b)/V(28.5b) * Re(8.85%) + D(1.05b)/V(28.5b) * Rd(34.70%) * (1-Tc(0.23)))
Discount Rate = 8.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.09 | Cagr: 0.11%
[DCF] Terminal Value 68.89% ; FCFF base≈1.45b ; Y1≈1.27b ; Y5≈1.03b
[DCF] Fair Price = 25.07 (EV 13.8b - Net Debt -47.0m = Equity 13.9b / Shares 553.5m; r=9.51% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.43 | # QB: 0
Revenue Correlation: 94.38 | Revenue CAGR: 0.59% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.07 | Chg30d=-0.68% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.61 | Chg30d=+0.13% | Revisions=+0% | GrowthEPS=+22.2% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=3.04 | Chg30d=-0.45% | Revisions=-17% | GrowthEPS=+14.8% | GrowthRev=+5.6%
[Analyst] Revisions Ratio: -18% (up=3, down=5)